Healthcare - Ethical & OTC Consumer - Cannabis spray offers hope to MS sufferers
Bayer Healthcare launched Sativex, the first cannabis-based medicine, in the UK in June 2010 to help treat spasticity associated with multiple sclerosis.

Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>